Frontlight ResearchEarly access
CompletedNo phase
Can Shock Indices Be Prognostic Indicators in Sepsis/Septic Shock?
Key facts
- Who runs it
- Başakşehir Çam & Sakura City Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 1,522 people enrolled
- Started
- 1 Dec 2012
- Ended
- 1 Feb 2024
- Type of study
- Observational
- Treatments tested
- Measurement of hemodynamic parameters.
- Record updated
- 16 May 2024
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients with a preliminary diagnosis of sepsis/septic shock in the intensive care unit
- Adult patients aged between 18 and 80 years
Who cannot take part
- Patients suspected of having COVID-19 pneumonia
- Patients with confirmed COVID-19, validated by thoracic computed tomography images and nasal swab PCR results
- Patients under 18 years old
- Pregnant patients
- Patients with incomplete data
- Patients for whom outcome information is unavailable due to referral to an external center
- Patients discharged from the intensive care unit within 24 hours
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
We evaluated the ability of shock indices and hemodynamic parameters to predict 28-day ICU mortality.
The group in the trial
- Group Sepsis
The group consists of 1,522 patients treated in the intensive care unit for sepsis/septic shock.
Treatment: Measurement of hemodynamic parameters.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 16 May 2024